360° SearchNetwork Hot Spots Trends Time Series

Advanced Search Options >>

Covance Inc

Type: Company

Name: Covance Inc

Nationality: United States

Web Address: http://www.covance.com/

Fact Sheet: Fact Sheet for Covance Inc

First reported 1 hour ago - Updated 1 hour ago - 1 reports

Form 4 COVANCE INC For: May 20 Filed by: Scodari Joseph C

StreetInsider.com - Form 4 COVANCE INC For: May 20 Filed by: Scodari Joseph C ... [Published Street Insider - 1 hour ago]

Entities: Covance Inc

First reported 1 hour ago - Updated 1 hour ago - 1 reports

Form 4 COVANCE INC For: May 20 Filed by: SHEARES BRADLEY T

StreetInsider.com - Form 4 COVANCE INC For: May 20 Filed by: SHEARES BRADLEY T ... [Published Street Insider - 1 hour ago]

Entities: Covance Inc

First reported 1 hour ago - Updated 1 hour ago - 1 reports

Covance Inc

Form 4 COVANCE INC For: May 20 Filed by: MCCARTNEY JOHN

StreetInsider.com - Form 4 COVANCE INC For: May 20 Filed by: MCCARTNEY JOHN ... [Published Street Insider - 1 hour ago]

Entities: Covance Inc

First reported May 21 2013 - Updated May 21 2013 - 1 reports

Covance Testing Method Named Industry Standard

-New method analyzes Vitamin D in infant formula-PRINCETON, NJ, May 20, 2013 - Covance Inc. (NYSE: CVD), one of the world's largest and most comprehensive drug development services companies, and a world leader in nutritional chemistry and food safety ... [Published Noodls - May 21 2013]

Entities: Covance Inc, Vitamin D, Food Safety, AOAC International, Chemistry

First reported May 17 2013 - Updated May 17 2013 - 1 reports

Barclays Capital Inc

Covance Price Target Increased to $55.00 by Analysts at Barclays Capital (CVD)

Investment analysts at Barclays Capital increased their target price on shares of Covance (NYSE: CVD)Shares of Covance (NYSE: CVD) traded down 0.21% during mid-day trading on Friday, hitting $76.72. Covance has a one year low of $44.19 and a one year ... [Published American Banking News - May 17 2013]

Entities: Covance Inc, Barclays Capital Inc, Stocks, New York Stock Exchange, First Analysis Securities Corp

First reported May 17 2013 - Updated May 17 2013 - 1 reports

New York Stock Exchange

Covance (CVD) Showing Bullish Technicals With Resistance At $78.23

Covance Inc (NYSE: CVD) closed Thursday's trading session at $76.88. In the past year, the stock has hit a 52-week low of $44.19 and 52-week high of $78.36. Covance (CVD) stock has been showing support around $75.71 and resistance in the $78.23 range. ... [Published MarketIntelligenceCenter.com - May 17 2013]

Entities: Covance Inc, New York Stock Exchange

First reported May 13 2013 - Updated May 13 2013 - 1 reports

Covance Inc. to Present at the Bank of America Merrill Lynch 2013 Health Care Conference

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!PRINCETON, N.J. , May 13, 2013 /PRNewswire/ -- Covance Inc. (NYSE: CVD) today announced that it will present at the Bank... ... [Published BioSpace - May 13 2013]

Entities: Covance Inc, Bank of America Merrill Lynch, Health Care

First reported May 13 2013 - Updated May 13 2013 - 2 reports

Covance To Present At The Bank Of America Merrill Lynch 2013 Health Care Conference PR Newswire

/PRNewswire/ --$ Covance Inc. (CVD) today announced that it will present at the Bank of America Merrill Lynch 2013 Health Care Conference on Wednesday, May 15, 2013 at 11:00 a.m. (ET). $ Investors may access a live webcast of the presentation at www.covance.com. ... [Published Yahoo! Finance - May 13 2013]

Entities: Covance Inc, Bank of America Merrill Lynch, Health Care

First reported May 13 2013 - Updated May 13 2013 - 1 reports

Covance (CVD) Trading Near $77.58 Resistance Level

Covance Inc (NYSE: CVD) closed Friday's trading session at $76.62. In the past year, the stock has hit a 52-week low of $44.19 and 52-week high of $78.36. Covance (CVD) stock has been showing support around $74.98 and resistance in the $77.58 range. Technical ... [Published MarketIntelligenceCenter.com - May 13 2013]

Entities: Covance Inc, New York Stock Exchange

First reported May 09 2013 - Updated May 09 2013 - 1 reports

Form 4 COVANCE INC For: May 07 Filed by: SHEARES BRADLEY T

StreetInsider.com - Form 4 COVANCE INC For: May 07 Filed by: SHEARES BRADLEY T ... [Published Street Insider - May 09 2013]

Entities: Covance Inc

First reported May 09 2013 - Updated May 09 2013 - 2 reports

Quintiles shares rise 11 percent in market debut

(Reuters) - Shares of drug research company Quintiles Transnational Holdings (Q.NThe Durham, North Carolina-based clinical trials company's initial public offerings is the largest among the 11 expected to be priced this week. The week could see the highest ... [Published Reuters - May 09 2013]

Entities: Quintiles, Drugs, Clinical trials, IPOs

First reported May 01 2013 - Updated May 01 2013 - 2 reports

Potential Covance (CVD) Trade Has $71.26 Breakeven

3 minutes ago, 8:28am (ET) 05/01/2013 FreshBrewedMediaCovance Inc (NYSE: CVD) closed Tuesday's trading session at $74.56. In the past year, the stock has hit a 52-week low of $44.19 and 52-week high of $75.73. Covance (CVD) stock has been showing support ... [Published Zecco - May 01 2013]

Entities: Covance Inc, Dividend Yield, New York Stock Exchange

Quotes

...of testing to sell globally," said Doug Winters, Executive Director, Science and Technology, Covance Nutritional Chemistry & Food Safety (NCFS). "We are proud that the Covance method was selected to be the industry standard."

Covance Testing Method Named Industry Standard [Published Noodls - May 21 2013]

...clinical trial data and support," said Jon Koch, corporate vice president and global general manager, Central Laboratory Services, Covance. "This expansion will help us better serve both our local and multinational customers' R&D needs in key therapeutic areas like oncology and metabolic diseases while reflecting Covance's continued commitment to the Asia Pacific region."

Covance Expands Singapore Central Lab [Published Contract Pharma - Apr 16 2013]

...on the fast growing opportunities in Asia," said Kevin Lai, Director, Biomedical Sciences Group, from the Economic Development Board of Singapore. "Its investment is a strong vote of confidenceconfidence in our efforts in developing Singapore as a leading biomedical sciences hub with strong capabilities to support translational and clinical research."

COVANCE INC.: Covance Expands Singapore Central Laboratory by 50 Percent to Meet Clients' Increas ... [Published 4 Traders - Apr 16 2013]

More From BioPortfolio on "Covance and M2Gen® Enter into Alliance to Promote Faster Patient Recruitment"

Covance and M2GenÂ Enter into Alliance to Promote Faster Patient Recruitment [Published BioPortfolio - Mar 04 2013]

More Content

sort by: Date \| Relevance
Form 4 COVANCE INC For: May 20 Filed by: SHEARE... [Published Street Insider - 1 hour ago]
Form 4 COVANCE INC For: May 20 Filed by: Scodar... [Published Street Insider - 1 hour ago]
Form 4 COVANCE INC For: May 20 Filed by: MCCART... [Published Street Insider - 1 hour ago]
Covance Testing Method Named Industry Standard [Published Noodls - May 21 2013]
Covance Price Target Increased to $55.00 by Ana... [Published American Banking News - May 17 2013]
Covance (CVD) Showing Bullish Technicals With R... [Published MarketIntelligenceCenter.com - May 17 2013]
Covance Inc. to Present at the Bank of America ... [Published BioSpace - May 13 2013]
Covance To Present At The Bank Of America Merri... [Published Yahoo! Finance - May 13 2013]
Covance To Present At The Bank Of America Merri... [Published Barchart - May 13 2013]
Covance To Present At The Bank Of America Merri... [Published PR Newswire: Health - May 13 2013]
ABCO Posts Solid 4Q and FY2013 Earnings - Analy... [Published Quote.com Australia - May 13 2013]
Covance (CVD) Trading Near $77.58 Resistance Level [Published MarketIntelligenceCenter.com - May 13 2013]
Covance In Retrospect: Shares Down 0.6% Since D... [Published Individual.com - May 10 2013]
Form 4 COVANCE INC For: May 07 Filed by: SHEARE... [Published Street Insider - May 09 2013]
Quintiles shares rise 11 percent in market debut [Published Reuters - May 09 2013]
Reuters – Quintiles Transnational Raises $947M ... [Published PE Hub News - May 09 2013]
UPDATE 1-Quintiles shares rise 11 pct in market... [Published London South East - May 09 2013]
Reuters – Quintiles IPO Raises More Than Planned [Published PE Hub News - May 09 2013]
UPDATE 1-Quintiles IPO raises more-than-planned... [Published Reuters - May 09 2013]
Covance Inc. to Present at the 2013 Growth Stoc... [Published BioSpace - May 07 2013]
Covance (CVD) Trading Near $73.46 Resistance Level [Published MarketIntelligenceCenter.com - May 07 2013]
COVANCE INC. : Covance To Present At The R. W. ... [Published 4 Traders - May 06 2013]
Covance To Present At The R. W. Baird 2013 Grow... [Published PR Newswire: Health - May 06 2013]
Covance Price Target Raised to $74.00 at Jeffer... [Published American Banking News - May 03 2013]
Covance PT Raised to $77.50 (CVD) [Published American Banking News - May 02 2013]
Covance Inc. Invites You to Join the Webcast of... [Published Zecco - May 02 2013]
Covance Inc. Invites You to Join the Webcast of... [Published PR Newswire: Health - May 02 2013]
Covance Q1 Results Top Estimates [Published RTTNews.com - May 02 2013]
Covance (CVD) Posts Quarterly Earnings, Beats E... [Published American Banking News - Earnings - May 01 2013]
Covance Reports First Quarter Net Revenue Growt... [Published PR Newswire: Health - May 01 2013]

Blogs

sort by: Date \| Relevance
Covance (CVD) Showing Bullish Technicals With R... [Published MarketIntelligenceCenter.com - May 17 2013] Covance Inc (NYSE: CVD) closed Thursday's trading session at $76.88. In the past year, the stock has hit a 52-week low of $44.19 and 52-week high of $78.36. Covance (CVD) stock has been showing support around $75.71 and resistance in the $78.23 range. ...
Covance (CVD) Trading Near $77.58 Resistance Level [Published MarketIntelligenceCenter.com - May 13 2013] Covance Inc (NYSE: CVD) closed Friday's trading session at $76.62. In the past year, the stock has hit a 52-week low of $44.19 and 52-week high of $78.36. Covance (CVD) stock has been showing support around $74.98 and resistance in the $77.58 range. Technical ...
Covance (CVD) Trading Near $73.46 Resistance Level [Published MarketIntelligenceCenter.com - May 07 2013] Covance Inc (NYSE: CVD) closed Monday's trading session at $73.13. In the past year, the stock has hit a 52-week low of $44.19 and 52-week high of $78.36. Covance (CVD) stock has been showing support around $72.58 and resistance in the $73.46 range. Technical ...
Potential Covance (CVD) Trade Has $71.26 Breakeven [Published MarketIntelligenceCenter.com - May 01 2013] Covance Inc (NYSE: CVD) closed Tuesday's trading session at $74.56. In the past year, the stock has hit a 52-week low of $44.19 and 52-week high of $75.73. Covance (CVD) stock has been showing support around $73.61 and resistance in the $75.17 range. ...
Covance (CVD) Showing Bullish Technicals But Co... [Published MarketIntelligenceCenter.com - Apr 25 2013] Covance Inc (NYSE: CVD) closed Wednesday's trading session at $74.62. In the past year, the stock has hit a 52-week low of $44.19 and 52-week high of $74.98. Covance (CVD) stock has been showing support around $74.02 and resistance in the $75.28 range. ...

Press Releases

sort by: Date \| Relevance
Covance To Present At The Bank Of America Merri... [Published PR Newswire: Health - May 13 2013]
Covance To Present At The R. W. Baird 2013 Grow... [Published PR Newswire: Health - May 06 2013]
Covance Inc. Invites You to Join the Webcast of... [Published PR Newswire: Health - May 02 2013]
Covance Reports First Quarter Net Revenue Growt... [Published PR Newswire: Health - May 01 2013]
Covance Expands Singapore Central Laboratory by... [Published PR Newswire: General Business - Apr 16 2013]